Adverum Biotechnologies, Inc. Common Stock
ADVM Real Time Price USDRecent trades of ADVM by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ADVM's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Modified aav capsids and uses thereof Jul. 09, 2024
-
Patent Title: Compositions and methods for enhanced gene expression Oct. 03, 2023
-
Patent Title: Variant aav capsids for intravitreal delivery Nov. 29, 2022
-
Patent Title: Mutant viral capsid libraries and related systems and methods Aug. 30, 2022
-
Patent Title: Compositions and methods for enhanced gene expression Jun. 07, 2022
-
Patent Title: Compositions and methods for enhanced gene expression in cone cells Feb. 15, 2022
-
Patent Title: Modified aav capsids and uses thereof Dec. 07, 2021
-
Patent Title: Compositions and methods for intravitreal delivery of polynucleotides to retinal cones Jun. 01, 2021
-
Patent Title: Mutant viral capsid libraries and related systems and methods Mar. 10, 2020
-
Patent Title: Compositions and methods for enhanced gene expression in cone cells Jun. 19, 2018
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ADVM in WallStreetBets Daily Discussion
Recent insights relating to ADVM
Recent picks made for ADVM stock on CNBC
ETFs with the largest estimated holdings in ADVM
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ADVM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.